Core Scientific Appoints Mark W. Adams to Board of Directors

Adams' Background in Technology Leadership

Mark W. Adams brings an extensive career spanning semiconductors, memory infrastructure, and artificial intelligence solutions. Most recently, Adams served as President, Chief Executive Officer, and Board Member of Penguin Solutions, Inc., a provider of memory and AI infrastructure, from August 2020 through January 30, 2026. Prior to his tenure at Penguin Solutions, Adams held the position of Chief Executive Officer at Lumileds, Inc., a global leader in LED lighting and original equipment manufacturer lighting solutions, serving from February 2017 until March 2019.

Before his roles in memory and lighting technology, Adams held significant positions within Micron Technology, one of the world's largest semiconductor companies. He served as President of Micron from 2012 to 2016 and held various other leadership roles within the company from 2006 through February 2012. This deep experience within Micron—spanning a critical period of technology advancement—has equipped Adams with substantial knowledge of memory solutions, semiconductor manufacturing, and enterprise technology infrastructure. His combined background positions him to contribute strategic insights relevant to emerging technology sectors including data infrastructure and computing solutions.

Independence Determination and Board Compliance

Core Scientific's Board of Directors conducted a comprehensive review of all relevant facts and circumstances regarding Adams' appointment and determined that he qualifies as an independent director under the independence requirements established by the Sarbanes-Oxley Act of 2002, as amended, and applicable listing standards of The Nasdaq Stock Market, LLC. This determination means Adams meets rigorous governance standards designed to ensure directors can exercise objective judgment on matters affecting the company.

The disclosure indicates no family relationships exist between Adams and any director or executive officer of Core Scientific. Additionally, Adams has no direct or indirect material interest in any related-party transactions requiring disclosure under Item 404(a) of Regulation S-K. The Board also confirmed that Adams' selection was not made pursuant to any arrangement or understanding with respect to any other person. These findings establish that Adams' appointment follows standard corporate governance protocols without conflicts of interest or undisclosed arrangements.

Current Board Positions and Industry Standing

Adams maintains active board positions at two other publicly traded technology companies, reflecting his standing and credibility within the industry. He currently serves as a member of the Board of Seagate Technology Holdings Public Limited Company, a leading data storage technology provider, and Cadence Design Systems, Inc., a major provider of electronic design automation software and hardware. These concurrent board roles demonstrate that Adams is sought after by established technology enterprises for his experience and judgment.

The combination of Adams' executive leadership experience and his participation on multiple boards of major technology companies suggests he brings both operational expertise and board-level perspective to Core Scientific. His involvement with companies spanning data infrastructure, design software, and hardware solutions provides him with insights across complementary technology domains. This portfolio of roles indicates Adams has maintained active engagement in the technology sector during his career transition from operating executive to board director.

Compensation Structure for Board Service

The disclosure states that Adams will receive cash and equity compensation for Board service commensurate with the Company's other non-employee directors. Core Scientific did not disclose the specific amount or structure of compensation in this announcement. This arrangement aligns with standard practice for board appointments, where new directors receive compensation packages consistent with existing board members to ensure fairness and maintain comparable incentive structures.

The use of both cash and equity components in director compensation is designed to align board members' interests with shareholder interests while providing appropriate remuneration for board service responsibilities. Investors seeking detailed information regarding the specific compensation amounts and vesting schedules would typically find such details in Core Scientific's proxy statement or annual proxy filing, rather than in an announcement of the appointment itself.

Timing of Announcement and Effective Date

Core Scientific issued a press release on July 29, 2026, announcing Adams' appointment, with the appointment becoming effective immediately upon announcement. The current report filing with the Securities and Exchange Commission was dated July 29, 2026, indicating the disclosure was made publicly on the same date as the appointment took effect. This immediate effectiveness means Adams began his service as a director without any transition period.

The simultaneous announcement and effective date represents a streamlined appointment process. By making the appointment effective immediately and announcing it the same day, Core Scientific provided the market with current information about its board composition without any period of uncertainty regarding when the new director would begin participating in board activities and decisions. This transparency allows investors and analysts to immediately factor the new board member into their assessment of company governance and strategic direction.

Regulatory Filings and Disclosure Requirements

Core Scientific disclosed the board appointment through a Form 8-K current report filing, which is the standard mechanism for reporting material events such as director appointments. The company furnished a press release as Exhibit 99.1 to the filing, incorporating it by reference into the formal SEC document. This dual disclosure approach—both the regulatory filing and the press release—ensures that the information reaches both regulatory authorities and public investors through established channels.

The Chief Legal Officer and Chief Administrative Officer, Todd M. DuChene, signed the Form 8-K filing on behalf of Core Scientific on July 29, 2026. The use of the CLO/CAO signature, rather than the CEO or CFO, reflects the nature of the filing as a governance matter rather than a financial or operational disclosure. The filing also included embedded Inline XBRL data, which provides structured financial and non-financial information in machine-readable format for enhanced searchability and data accessibility.

Core Scientific's Business Context and Board Strengthening

Core Scientific, Inc. is a Delaware corporation with principal executive offices located at 838 Walker Road, Suite 21-2105, Dover, Delaware. The company's common stock trades on The Nasdaq Global Select Market under the ticker symbol CORZ, while its warrants trade under tickers CORZW and CORZZ, reflecting different exercise prices of $6.81 and $0.01 per share respectively. The appointment of Adams, with his extensive background in semiconductors, memory solutions, and AI infrastructure, suggests the board is positioning itself with expertise relevant to technology-intensive business operations.

Adams' experience with memory infrastructure and artificial intelligence solutions may be particularly relevant to Core Scientific's operational strategy and market positioning. His previous leadership of Penguin Solutions, which specializes in memory and AI infrastructure, provides direct familiarity with technology domains that increasingly intersect with data center operations, computational infrastructure, and emerging applications. The timing of this appointment in July 2026 indicates Core Scientific's board is actively enhancing its composition to address current and anticipated strategic priorities within the technology sector.

What Investors Should Monitor Following This Appointment

Investors holding Core Scientific securities may wish to monitor how Adams' participation influences board-level discussions regarding the company's strategic direction, capital allocation, and technology development priorities. New board members often bring different perspectives and priorities that may shape committee assignments, governance practices, or strategic initiatives. Adams' expertise in memory and AI infrastructure, combined with his experience at companies like Micron and Penguin Solutions, may influence conversations about technology partnerships, infrastructure investments, or product development strategies.

Additionally, investors should review Core Scientific's upcoming proxy statement, which will provide detailed information about Adams' specific board committee assignments, the full compensation package approved for his service, and any other governance changes implemented in connection with his appointment. The proxy statement will also offer expanded biographical information and details about Adams' experience relevant to the company's business. Shareholders may also track whether Adams' appointment leads to other board changes, as new director appointments sometimes coincide with broader governance restructuring or strategic pivots.